电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

ABR 抗体 (AA 797-859) (FITC)

This FITC-conjugated 兔 多克隆 anti-ABR antibody specifically detects ABR in not_set. The antibody is reactive with 人 samples.
产品编号 ABIN7143172
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for ABR 抗体 (AA 797-859) (FITC) (ABIN7143172)

抗原

See all ABR 抗体
ABR (Active BCR-Related (ABR))

适用

  • 18
  • 5
  • 2

宿主

  • 15
  • 3

克隆类型

  • 18
多克隆

标记

  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ABR antibody is conjugated to FITC

应用范围

请咨询
  • 抗原表位

    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 797-859

    原理

    ABR Antibody, FITC conjugated

    纯化方法

    Protein G purified

    纯度

    >95 %

    免疫原

    Recombinant Human Active breakpoint cluster region-related protein (797-859AA)

    亚型

    IgG
  • 限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    储存液

    ProClin

    注意事项

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C,-80 °C

    储存方法

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原

    ABR (Active BCR-Related (ABR))

    别名

    ABR

    背景

    Background: GTPase-activating protein for RAC and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them.

    Aliases: abr antibody, ABR_HUMAN antibody, Active BCR related antibody, Active BCR related gene antibody, Active breakpoint cluster region related protein antibody, Active breakpoint cluster region-related protein antibody, MDB antibody

    UniProt

    Q12979

    途径

    Neurotrophin Signaling Pathway, Regulation of Leukocyte Mediated Immunity
You are here: